News

Anticholinergics could confer an increased risk, one dependent on the dose and amount of use. Give them to older patients or consider alternatives?

Symptoms occur in nearly 1 in 5 adults who have epilepsy. Their presence may have severe implications for patients’ quality of life.

A new study indicates that infection with Helicobacter pylori might lower the risk of multiple sclerosis, at least in women. Pharmaceutical products could provide a novel means of treatment.

Orexin B protects vulnerable midbrain neurons from degeneration and preserves their function. This sleep-promoting protein could provide a new target for potential treatments.

Despite butterbur’s potential efficacy, doubts are increasing about its long-term safety given of the risk of liver damage and the lack of an actively regulated preparation.

The risk of progressive multifocal leukoencephalopathy in patients receiving Tysabri for MS is a concern about this otherwise extremely effective therapy.

HDIT/HCT could induce sustained remission and neurological improvements in patients with multiple sclerosis.

Inquiring about memory in older persons during routine clinical examination may identify persons who might be at higher risk for stroke.

This report reflects the changing nature of guidelines toward evidence-based treatment rather than expert opinion. A companion piece will help translate evidence-based guidelines to clinical practice.

Men and women smoke for different reasons and activate different parts of the brain while smoking. These findings from “dopamine movies” could have implications for Parkinson disease.

Prostaglandin may block protective microglial cells in Alzheimer disease, a study shows. This work could form the basis for future therapies.

This is a newly identified association between the conditions, and they may share a common underlying link.

By localizing the portion of the brain responsible for seizures and envisioning long-term outcomes, this imaging combination helps guide clinical decision making.

Many patients with brain tumors present with isolated headaches but no other symptoms. Use neuroimaging to help the diagnosis, or cut costs?

Transcranial magnetic stimulation is a promising, effective, well-tolerated and safe treatment option for migraine with and without aura, episodic or chronic.

Chemotherapy-induced peripheral neuropathy affects nearly half of adult cancer patients; a new review finds that there is currently no way to predict who will be affected.

This yellow CSF was drawn from an HIV-positive man who presented with status epilepticus. What is the most likely cause?

These review articles published in 2014 cover a variety of headache issues, and all are free courtesy of PubMed. Take a look.

Recovery from a paralyzed limb may be enhanced by a combination of these elements.

New research sheds light on epilepsy concerns, particularly the link between cardiac abnormalities and sudden unexpected death.

Parkinson and other neurodegenerative diseases are hard to distinguish. Surface-based MRI shows promise as a diagnostic tool.

Get to the root of the latest research findings on nervous system disorders and test your brainpower with this quick 5-question quiz.

Identification of a brain circuit implicated in Alzheimer disease and schizophrenia could aid in comprehension of brain disorders and point to prevention strategies.

Pain relief is better with a triple combination medication that includes acetaminophen than with acetaminophen by itself, researchers found, suggesting a new therapeutic option.

Study results suggest that more stimulating work environments may help people retain their cognitive abilities.

The use of a stroke emergency mobile unit speeds thrombolysis and thus improves short-term outcomes, with no risk to patients’ safety.

The ketogenic and the modified Atkins diets, high in fat and low in carbohydrates, could reduce these seizures, suggesting that clinicians bring them into the treatment discussion.

The latest scientific developments about the brain and how it works were presented this week at the annual meeting of the Society for Neuroscience. Potential new treatments were identified.

These findings advance knowledge about the link between brain inflammation and the progression of brain disorders and suggest possible targets for future treatments.

Approved for patients with relapsing forms of MS, the drug generally should be reserved for those who have had an inadequate response to 2 or more drugs indicated for MS treatment.